Profile for European Patent Office Patent: 1043327
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Denmark | CA 2013 00003 | ⤷ Start Trial |
| Netherlands | C300568 | ⤷ Start Trial |
| Luxembourg | 92134 | ⤷ Start Trial |
| Ireland | 2013/001 | ⤷ Start Trial |
| France | 13C0008 | ⤷ Start Trial |
| Sweden | 1390003-0 | ⤷ Start Trial |
| Finland | 422 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1043327
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
